Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
Abstract: This paper explores the intersection of digital twin technology and Programmable Logic Controllers (PLCs) within the scope of industrial automation, emphasizing the transformative potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback